Ariel Capital Advisors Lowers stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Ariel Capital Advisors reduced its stake in UnitedHealth Group Inc by 0.97% during the most recent quarter end. The investment management company now holds a total of 18,882 shares of UnitedHealth Group Inc which is valued at $2,493,179 after selling 185 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on May 3, 2016.UnitedHealth Group Inc makes up approximately 2.18% of Ariel Capital Advisors’s portfolio.

Other Hedge Funds, Including , Boston Financial Mangement Inc reduced its stake in UNH by selling 670 shares or 2.34% in the most recent quarter. The Hedge Fund company now holds 27,939 shares of UNH which is valued at $3,689,066. UnitedHealth Group Inc makes up approx 0.55% of Boston Financial Mangement Inc’s portfolio.Hoxton Financial boosted its stake in UNH in the latest quarter, The investment management firm added 2,599 additional shares and now holds a total of 2,876 shares of UnitedHealth Group Inc which is valued at $378,712. UnitedHealth Group Inc makes up approx 0.19% of Hoxton Financial’s portfolio.Deltec Asset Management boosted its stake in UNH in the latest quarter, The investment management firm added 20,000 additional shares and now holds a total of 47,700 shares of UnitedHealth Group Inc which is valued at $6,281,136. UnitedHealth Group Inc makes up approx 1.55% of Deltec Asset Management’s portfolio.

UnitedHealth Group Inc opened for trading at $132.92 and hit $133.6 on the upside on Tuesday, eventually ending the session at $133.57, with a gain of 0.68% or 0.9 points. The heightened volatility saw the trading volume jump to 22,23,552 shares. Company has a market cap of $126,999 M.

On the company’s financial health, UnitedHealth Group Inc reported $1.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.72. The company had revenue of $44527.00 million for the quarter, compared to analysts expectations of $44278.96 million. The company’s revenue was up 24.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. Company shares were Reiterated by Mizuho on Apr 20, 2016 to “Buy”, Firm has raised the Price Target to $ 156 from a previous price target of $150 .Company shares were Reiterated by FBR Capital on Apr 19, 2016 to “Outperform”, Firm has raised the Price Target to $ 145 from a previous price target of $130 .Company shares were Reiterated by Mizuho on Mar 15, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $131 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Leave a Reply

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.